[Clinical study of the broncho-relaxing action of a new sympathicomimetic drug on twenty patients with chronic obstructive lung disease (author's transl)].
D000328:Adult; D000336:Aerosols; D000368:Aged; D000403:Airway Resistance; D001794:Blood Pressure; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D009921:Metaproterenol / Q000627:therapeutic use*; D008875:Middle Aged; D010636:Phenols / Q000627:therapeutic use; D011660:Pulmonary Heart Disease / Q000150:complications; D013566:Sympathomimetics / Q000627:therapeutic use*; D013997:Time Factors
D000336:Aerosols; D001993:Bronchodilator Agents; D010636:Phenols; D013566:Sympathomimetics; D009921:Metaproterenol
Etude clinique de l'effet bronchodilatateur d'un nouveau sympathicomimétique chez 20 patients atteits de bronchopneumopathie chronique obstructive sévère.